Trial Profile
A Randomized Phase II Study of Oxaliplatin and S-1 (SOX) Versus Oxaliplatin and Capecitabine (XELOX) in Patients With Peritoneal Metastasis of Colorectal Cancer
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 04 Jun 2019
Price :
$35
*
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Oxaliplatin (Primary) ; Capecitabine
- Indications Cancer metastases; Colorectal cancer
- Focus Therapeutic Use
- 20 Aug 2016 New trial record